Clinical Trials Browser

Phase 3 × Rectal Neoplasms × Epoetin Alfa × Clear all

NCT00254436 2018-10-25

A Double-Blind, Randomized, Placebo-Controlled Study of the Efficacy and Safety of Weekly Procrit Given to Gastric or Rectal Patients

Phase 3 Terminated

Gastrointestinal

Gastrointestinal Neoplasms, Rectal Neoplasms